SEC Form 4 Summary RPRX

Royalty Pharma's Christopher Hite sells 100,000 shares

Christopher Hite sold 100,000 Royalty Pharma (RPRX) shares for $6,814,710 on November 17, 2026.

Transaction Value:
$6,814,710.00
Shares transacted:
100,000
Average price:
$68.15
Insider:

The Form 4 filing was submitted on November 18, 2026, one day after the sale. This SEC form reports changes in an insider's stock ownership. Christopher Hite serves as Royalty Pharma's executive vice president and chairman of partnering.

Transaction details

Transaction
Date of Earliest Transaction2026-11-17
Date of Latest Transaction2026-11-17
Buy/Sellsell
Transaction Count1
Shares Transacted100,000
Price$68.15
Total Transaction Value$6,814,710.00
Insider
Ticker SymbolRPRX
CompanyRoyalty Pharma plc
Insider NameHite Christopher
Insider TitleEVP & Chairman, Partnering
Sector - IndustryHealthcare - Biotechnology
Holdings
Total Shares Owned After Transaction177,523
Position Size Change36.03%
Filing
Filing Date2026-11-18
SEC LinkView filing

FAQ

What type of transaction is this?

This was a sale of RPRX shares, reported under SEC transaction code S. The filing lists one sale transaction.

What was the average price of the transaction?

The average sale price was $68.1471 per share. That rounds to $68.15, the price shown in the transaction details.

How did this transaction affect the insider's holdings?

The sale reduced the reported holdings by 100,000 shares, leaving 177,523 shares owned afterward. The shares sold made up 36.03% of the 277,523 shares held before the sale. These figures describe the reported share balance, rather than all assets the insider may own.

What's the total transaction value?

The total value of the single sale was $6,814,710.00 when rounded to cents.

Are there any special circumstances around this transaction?

The available information includes a Rule 10b5-1 trading plan reference. These plans set trading instructions in advance. No footnote text was available to confirm whether the reference covers this sale specifically or the filing as a whole. The plan's start date and trading schedule are unknown.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 0.60 seconds
  • Alert intervals starting from one minute
  • Real time alert directory updates
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.